Pages that link to "Q43812671"
Jump to navigation
Jump to search
The following pages link to An effect-size analysis of the relative efficacy and tolerability of serotonin selective reuptake inhibitors for panic disorder. (Q43812671):
Displaying 47 items.
- Diagnosis and Treatment of Agoraphobia with Panic Disorder (Q22305826) (← links)
- Antidepressants and benzodiazepines for panic disorder in adults (Q24187763) (← links)
- Antidepressants versus placebo for panic disorder in adults (Q24201481) (← links)
- Prevalence of attention deficit/hyperactivity disorder among adults in obesity treatment (Q24791399) (← links)
- Propranolol for the treatment of anxiety disorders: Systematic review and meta-analysis (Q26781133) (← links)
- Canadian clinical practice guidelines for the management of anxiety, posttraumatic stress and obsessive-compulsive disorders (Q27009995) (← links)
- Emerging drugs for the treatment of anxiety (Q28083141) (← links)
- The efficacy of paroxetine and placebo in treating anxiety and depression: a meta-analysis of change on the Hamilton Rating Scales (Q28542596) (← links)
- Advances in the treatment of anxiety: targeting glutamate (Q30457479) (← links)
- Indirect comparisons: a review of reporting and methodological quality (Q33750311) (← links)
- Panic disorder (Q33999587) (← links)
- Psychopharmacology of anxiety disorders. (Q34228150) (← links)
- The role of alprazolam for the treatment of panic disorder in Australia (Q34258725) (← links)
- Panic-focused psychodynamic psychotherapy in a woman with panic disorder and generalized anxiety disorder (Q34303419) (← links)
- Evidence-based guidelines for the pharmacological treatment of anxiety disorders: recommendations from the British Association for Psychopharmacology (Q34465555) (← links)
- Cannabidiol as a Potential Treatment for Anxiety Disorders (Q34492624) (← links)
- Pharmacotherapy of anxious disorders (Q35011794) (← links)
- Cognitive-behavioral therapy for panic disorder: a review of treatment elements, strategies, and outcomes (Q35138635) (← links)
- Pharmacotherapy of anxiety disorders: a critical review (Q35686859) (← links)
- Lifestyle Behaviours Add to the Armoury of Treatment Options for Panic Disorder: An Evidence-Based Reasoning (Q35791127) (← links)
- Venlafaxine extended release (XR) in the treatment of panic disorder (Q35919158) (← links)
- Management of panic disorder (Q36106827) (← links)
- Paroxetine in panic disorder: clinical management and long-term follow-up (Q36107073) (← links)
- Predictors of pharmacotherapy response in anxiety disorders (Q36228205) (← links)
- Mood and anxiety disorders in chronic headache (Q36620677) (← links)
- Pharmacological management of panic disorder (Q36836798) (← links)
- Treatment of panic disorder: recent developments and current status (Q37232022) (← links)
- Treatment of comorbid anxiety and autism spectrum disorders (Q37257081) (← links)
- Comparison of combined psycho- and pharmacotherapy with monotherapy in anxiety disorders: controversial viewpoints and clinical perspectives (Q37276666) (← links)
- Psychiatric treatment received by primary care patients with panic disorder with and without agoraphobia (Q37317616) (← links)
- New treatment options for panic disorder: clinical trials from 2000 to 2010 (Q37845855) (← links)
- Evidence-based pharmacotherapy of panic disorder: an update (Q37898209) (← links)
- The diagnostic value of clinical EEG in detecting abnormal synchronicity in panic disorder. (Q37922727) (← links)
- Antidepressants and benzodiazepines for panic disorder in adults. (Q38952014) (← links)
- SSRIs vs. TCAs in the treatment of panic disorder: a meta-analysis (Q44115958) (← links)
- 5-HT1A responsivity in patients with panic disorder before and after treatment with aerobic exercise, clomipramine or placebo (Q44428968) (← links)
- Australian and New Zealand clinical practice guidelines for the treatment of panic disorder and agoraphobia (Q44667926) (← links)
- An effect-size analysis of pharmacologic treatments for generalized anxiety disorder (Q46913592) (← links)
- Does cognitive behavioral therapy alter mental defeat and cognitive flexibility in patients with panic disorder? (Q47556429) (← links)
- Detecting panic disorder in medical and psychosomatic outpatients: comparative validation of the Hospital Anxiety and Depression Scale, the Patient Health Questionnaire, a screening question, and physicians' diagnosis. (Q52007288) (← links)
- Antidepressants versus placebo for panic disorder in adults. (Q52604885) (← links)
- Anxiety disorders in older adults (Q56780652) (← links)
- Predictive modeling in e-mental health: A common language framework (Q60450692) (← links)
- Pharmacological Therapy in Panic Disorder: Current Guidelines and Novel Drugs Discovery for Treatment-resistant Patient (Q64078234) (← links)
- Benzodiazepines: Revisiting Clinical Issues in Treating Anxiety Disorders (Q81667961) (← links)
- Panic disorder (Q83839621) (← links)
- Systematic review and meta-analysis: Dose-response curve of SSRIs and SNRIs in anxiety disorders (Q93384692) (← links)